Hemispherian AS Alternatives & Competitors

12 companies similar to Hemispherian AS — Hemispherian is a biotechnology company developing new treatments for the most a...

Kintara Therapeutics, Inc. NASDAQ: KTRA

Seeking New Horizons for Cancer Patients

8 Grant $132.83M

San Diego, United States

Biotechnology Health Care

Notable

Notable is a mission-driven company transforming the way cancer is treated

33 $71.35M

Foster City, United State...

Biotechnology Health Care

Tradewind BioScience

Innovative therapeutics for the most aggressive cancers

5 Seed $120.00K

United States

Biotechnology Health Care

Alpheus Medical, Inc

Changing the way cancer is treated.

9 Series B $82.00M

Oakdale, United States

Biotechnology Health Care

Rival Readout

Competing with Hemispherian AS? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

iOnctura

Developing precision small molecules to combat hard-to-treat tumors.

28 Series B $118.37M

Geneve, Switzerland

Biotechnology Health Care +2

Novelogics Biotechnology Inc.

Pre-clinical stage biotech company developing an antibody immunotherapy drug for cancer us...

1 Angel

Canada

Biotechnology Health Care +1

OncoSynergy

Physician-founded, patient-focused.

4 Growth $9.86M

Stamford, United States

Biotechnology Health Care +1

Fore Biotherapeutics

A precision oncology company rooted in science and innovation, developing cancer therapies...

46 Series D $166.50M

Philadelphia, United Stat...

Biotechnology Health Care

Tango Therapeutics

Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of preci...

182 Post-IPO Equity $351.00M

Boston, United States

Biotechnology Health Care +1

Faeth Therapeutics

Unlocking the power of metabolism to treat cancer.

28 Series A $67.00M

United States

Biotechnology Health Care +1

Madison Vaccines

Developing innovative vaccines for prostate cancer patients and a test to determine their...

Venture round $15.81M

Biotechnology Health Care +1

Boundless Bio

Unbound by convention, bound to save lives

44 Series C $251.40M

San Diego, United States

Biotechnology Health Care +2

About Hemispherian AS

Hemispherian AS is a biotechnology company based in Norway, founded in 2015. Their mission is to develop new treatments for the most aggressive types of cancer, with a focus on creating a new drug to treat Glioblastoma Multiforme (GBM). They aim to significantly increase life expectancy for patients, improve patient co...

Business keywords

Cancer Treatment, Glioblastoma Multiforme, Drug Development, Life Expectancy Improvement, Patient Comfort, Survival Rates, Aggressive Cancer, Oncology, Innovation, Clinical Research, Precision Medicine

Frequently Asked Questions

Companies similar to Hemispherian AS include Kintara Therapeutics, Inc. NASDAQ: KTRA, Notable, Tradewind BioScience, Alpheus Medical, Inc, iOnctura. They work in Biotechnology and Health Care and share Hemispherian AS's focus on cancer treatment, oncology and precision medicine.

Bounce Watch lists 12 companies that share Hemispherian AS's industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Hemispherian AS: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Hemispherian AS Profile Kintara Therapeutics, Inc. NASDAQ: KTRA Alternatives Notable Alternatives Tradewind BioScience Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Hemispherian AS on 11 Sep 2024. The 12 companies listed here were last checked between 25 Jul 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.